From Tantalizing Hints of Progress Against ALS for Cytokinetics, Others:

Cytokinetics Logo
Cytokinetics Logo

Cytokinetics (NASDAQ: CYTK) is a South San Francisco-based drug company developing treatments for neurological conditions such as amyotrophic lateral sclerosis (Lou Gehrig’s Disease).